Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK715m

    Last close

    SEK13.80

    ▲ −0.30 (−2.13%)

    VolitionRx

    MCap

    USD56m

    Last close

    USD0.60

    ▲ 0.00 (−0.66%)

    Portobello SpA

    MCap

    EUR16m

    Last close

    EUR2.90

    ▲ 0.52 (21.85%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive Interview – EMIS Group

Executive Interview – EMIS Group

EMIS Group — 11 videos in collection

More on this equity

EMIS is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 55% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. The company’ strategy is to provide connected healthcare solutions to facilitate patient-centric care.

< Previous
Next >

You may also be interested in these:

TMT

EMIS Group FY21 results – executive interview

TMT

EMIS Group – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free